Advances in Hematological Malignancies
Recent decades have witnessed remarkable advancements in the domain of hematological malignancies. Novel therapies such as targeted drugs, immunotherapies, and gene editing are transforming the outlook for patients with blood cancers. Clinical trials continue to explore these innovative approaches, offering potential for more effective treatment op